Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Seqirus,"Quadrivalent Influenza virus haemagglutinin, surface antigen, inactivated, prepared in cell cultures",Prevention of influenza caused by Influenza Virus Types A and B,"Quadrivalent Influenza virus haemagglutinin, surface antigen, inactivated, prepared in cell cultures (FlucelvaxÂ® Quad)",Recommended for decline,Community and Hospital,
